Review
Copyright ©The Author(s) 2023.
World J Gastroenterol. May 21, 2023; 29(19): 2888-2904
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2888
Table 2 Summary of the most important published papers regarding the usefulness of radiomics in colorectal cancer patients using magnetic resonance imaging
Ref.
Imaging
Main aim
Patients (n)
Main findings
Horvat et al[52], 2022MRIResponse to chemotherapy114Combined radiological-radiomics model increased agreement (κ = 0.82 vs κ = 0.25)
Dinapoli et al[53], 2018MRIPathological complete response221Significant covariates, skewness, and entropy can predict pathological complete response, with AUCs = 0.730 and 0.750 for internal and external cohorts
Shahzadi et al[50], 2022MRIResponse to chemotherapy190Radiomics combined with the T stage better predict response
Liu et al[23], 2021MRIPrediction of nodes metastases186Clinical-radiomics model improves performance: AUC = 0.827
Chen et al[72], 2022MRITumor differentiation and nodes metastases37 (487 nodes)Radiomics features of the primary tumor can predict tumor differentiation: AUC = 0.798
Liu et al[73], 2017MRITumor differentiation68Skewness and entropy are lower in pT1-2 in comparison with pT3-4 (P < 0.05)
Yang et al[74], 2019MRIPrediction of T and N stage88Skewness, kurtosis, and energy are higher in metastatic nodes in comparison with non-metastatic ones (P < 0.001)
Ma et al[75], 2019MRIPrediction of nodes metastases and N staging152SVM has higher diagnostic values for T and N stages (AUC = 0.862) in comparison with MLP and RF
Zhu et al[76], 2019MRIPrediction of nodes metastases215Radiomic model AUC = 0.818
Zhou et al[77], 2020MRIPrediction of nodes metastases391The combined model predicts nodes metastases: NPV = 93.7%, AUC = 0.818
Shu et al[34], 2019MRIPrediction of synchronous liver metastases194The Radiomics model combined clinical risk factors and LASSO features and showed a good predictive performance: AUC = 0.921
Liu et al[107], 2020MRIPrediction of synchronous liver metastases127A radiomic nomogram presents an accuracy of 81.6% in predicting liver metastases (AUC = 0.918)
Granata et al[115], 2022MRIPrediction of overall survival90Second-order features can predict infiltrative tumor growth, tumor budding, and mucinous type; a second-order feature can predict the risk of recurrence with an accuracy of 90%
Jalil et al[119], 2017MRIPrediction of prognosis after chemotherapy56MPP can predict overall survival (HR = 6.9) and disease-free survival (HR = 3.36); texture analysis can predict relapse-free survival on pre- and post-treatment analyses